Skip to content

Treatment of Toothache with Unani medicine Raughan -e-Qaranful

Clinical Validation of Unani Pharmacopoeial Formulation Raughan -e-Qaranful in Waja al-Asnan (Toothache)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020516
Enrollment
240
Registered
2019-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K14- Diseases of oral cavity and salivary glands

Interventions

Intervention1: Raughan -e-Qaranful: Local application twice a day for 3 days.(Soak a cotton swab in the oil and apply gently to the aching tooth) Control Intervention1: Nil: Nil

Sponsors

Central Council for Research in Unani Medicine CCRUM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The following criteria will be strictly followed for inclusion of cases in this observational study. 1. Patients of either sex in the age group 18-65 years. 2. Patients having Waja al-Asnan (Toothache) with or without any of the following symptoms: i. Waram al-Lisa (Gingival swelling) ii. Humra al-Lisa (Gingival erythema) iii. HassÄ?siyat HarÄ?riyya (Thermal sensitivity) â?? Pain triggered by Cold or Heat iv. Headache 3. Patients with Waja al-Asnan (Toothache) ranging from 1-5 on Numeric Analogue Scale (NAS)

Exclusion criteria

Exclusion criteria: 1. Patients with Waja al-Asnan (Toothache) ranging from 6-10 on Numeric Analogue Scale (NAS) 2. Known case of Neurological disorders 3. Known case of Oro-facial abscess and Cellulitis 4. Presence of concomitant Oral pain due to Oral ulcers 5. Known cases of Upper Respiratory tract Infection (URTI) 6. Known cases of severe Renal/ Hepatic/ DM 7. Pregnant and lactating women 8. History of Hypersensitivity/non-responsive to the study drug or any of its ingredients 9. History of addiction (alcohol, drugs) 10. Patients currently on antibiotic therapy 11. Pericoronitis (Pain due to eruption of third molar)

Design outcomes

Primary

MeasureTime frame
Improvement in sign and symptoms of Waja al-Asnan (Toothache)Timepoint: 3days

Secondary

MeasureTime frame
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026